ARGS

Argos Therapeutics, Inc.
ARGS

Overview Fund Activity
Delisted

ARGS was delisted on the 24th of April, 2018.

Back to rankings

29 hedge funds and large institutions have $2.89M invested in Argos Therapeutics, Inc. in 2017 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
29
Holders Change
-5
Holders Change %
-14.71%
% of All Funds
0.72%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
6
Increased
6
Reduced
8
Closed
11
Calls
$956K
Puts
$36K
Net Calls
+$920K
Net Calls Change
-$1M

Top Buyers

1
WA
Wasatch Advisors
Utah
$120K
2
TSS
Two Sigma Securities
New York
$27K
3
KeyBank National Association
KeyBank National Association
Ohio
$22K
4
UBS Group
UBS Group
Switzerland
$17K
5
Vanguard Group
Vanguard Group
Pennsylvania
$152K

Top Sellers

1
Goldman Sachs
Goldman Sachs
New York
$0
2
ECM
Element Capital Management
New York
$0
3
Morgan Stanley
Morgan Stanley
New York
$0
4
PP
Paloma Partners
Connecticut
$0
5
LP
LMR Partners
United Kingdom
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
ECM
26
Element Capital Management
New York
– -$30K -4,140 Closed
Morgan Stanley
27
Morgan Stanley
New York
– -$19K -2,660 Closed
PP
28
Paloma Partners
Connecticut
– -$17K -2,305 Closed
LP
29
LMR Partners
United Kingdom
– -$16K -2,251 Closed
Susquehanna International Group
30
Susquehanna International Group
Pennsylvania
– -$11K -1,564 Closed
Citadel Advisors
31
Citadel Advisors
Florida
– -$7K -899 Closed
Squarepoint
32
Squarepoint
New York
– -$5K -715 Closed
Creative Planning
33
Creative Planning
Kansas
– -$2K -300 Closed
TRCT
34
Tower Research Capital (TRC)
New York
– -$2K -246 Closed
1
2